Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 13, 2023 CHI ADVISORS LLC
4 Feb 9, 2023 FORM 4 SUBMISSION
3 Feb 9, 2023 FORM 3 SUBMISSION
8-K Feb 7, 2023 8-K
4 Feb 2, 2023 FORM 4 SUBMISSION
4 Feb 2, 2023 FORM 4 SUBMISSION
SC 13G/A Jan 23, 2023
8-K Jan 9, 2023 8-K
EFFECT Nov 21, 2022
CORRESP Nov 18, 2022
UPLOAD Nov 16, 2022
SC 13G/A Nov 14, 2022 SC 13G/A
S-3 Nov 10, 2022 S-3
10-Q Nov 10, 2022 10-Q
8-K Nov 10, 2022 8-K
8-K Oct 20, 2022 8-K
4 Sep 20, 2022
3 Sep 20, 2022
4 Sep 20, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 19, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 19, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
SC 13D/A Sep 16, 2022
8-K Sep 14, 2022 8-K
424B5 Sep 14, 2022 424B5
8-K Sep 14, 2022 8-K
← Newer Page 8 of 28 · 693 filings Older →